WINDOME BANKING was honoured to be part of this Fall’s Inaugural Edition of the new Medical Aesthetics Conference at the Think.in Injectable Summit in Marbella on October 4-5.
WINDOME BANKING was honoured to be part of this Fall’s Inaugural Edition of the new Medical Aesthetics Conference at the Think.in Injectable Summit in Marbella on October 4-5. This unveiled a number of game-changing innovative players further pushing back the frontiers of constant transformation in this industry. We had the pleasure of reporting on overarching megatrends and new catalyst of the medical aesthetic, novel class of skinboosters, dermocosmetic and regenerative markets heralding a new era in China and discuss the challenging developments of the NMPA regulation elevating its standards as patient safety gains more paramount importance than ever while the prerequisite for clinical trials deign, patient eligibility and exclusion as well as minimum efficacy requirement and the accuracy and reliability of biostatistical analyses. This is propelled by overarching universal trends such ageing, urbanization, the massive spreading of prejuvenation to prevent the first signs of ageing, a gradual evolution of aesthetics from an aspirational lifestyle choice to what is considered must-have basic human right by the upcoming generation under pressure of ubiquitous social media. The massive GLP-1 fat-loss treatment phenomenon fueled by the mounting success of Ozempic, Wegowy, Mounjaro and Zepbound in North America creates a growing demand for facial wrinkling and anti-ageing treatment which is increasingly addressed by a new generation of biostimulators based on PDLA, PLLA, HA combined with PLLA, PMMA, PDRN/PN, PCL and other biopolymers completed by regenerative medicine treatments driven by exosomes, microbiota, telomerase inhibitors, anti-glycation, as well as anti-oxidation ingredients.
This is of course also driven by increasing demand of an ever more digital hyperconnected Millennial and GenZ patient, empowered by social network fully dedicated to beauty, aesthetic and skincare such as SoYoung or Gengmei which have emerged victorious from the COVID crisis. It is further fostered by largely accelerated by technological advancements unleashing the power of genomic, stem cell research and new groundbreaking discoveries of gene therapy. The velocity of this transformation should further ramp up with the potential advancements that AI, robotics and 3D Bioprinting might bring in the years ahead. Let’s explore and discus the disruptive impact of these transformative trends with the panelists. We also had the pleasure to moderate a great Speakers’ panel in a roundtable on Private equity in aesthetic centers acquisition and review notably the impact of their engagement in terms of deployment of national, regional or global networks, vertical integration or digitalization of processes and AI/GenAI penetration.
